Ikeda N, Hasegawa T, Hasegawa T, Saito I, Saruta T : Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004. J Hum Hypertens 2006; 20 : 263–266. Article CAS Google Scholar Nagai Y, Yao L, Kobori H, et al : Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005; 16 : 703–711. Article CAS Google Scholar Hilgers KF, Veelken R : Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol 2005; 16 : 574–575. Article Google Scholar ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288 : 2981–2997. Dahlof B, Devereux RB, Kjeldsen SE, et al , LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359 : 995–1003. Article CAS Google Scholar Pfeffer MA, Swedberg K, Granger CB, et al , CHARM Investigators and Committees : Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362 : 759–766. Article CAS Google Scholar Julius S, Nesbitt SD, Egan BM, et al , Trial of Preventing Hypertension (TROPHY) Study Investigators : Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354 : 1685–1697. Article CAS Google Scholar Nakaya H, Sasamura H, Hayashi M, Saruta T : Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 2001; 12 : 659–666. CAS PubMed Google Scholar Nakaya H, Sasamura H, Kitamura Y, et al : Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22 : 303–312. Article CAS Google Scholar Ishiguro K, Sasanuma H, Sakamaki Y, Itoh H, Saruta T : Developmental activity of the renin-angiotensin system during the “critical period” modulates later L-NAME–induced hypertension and renal injury. Hypertens Res 2007; 30 : 63–75. Article CAS Google Scholar Airoldi F, Palatresi S, Marana I, et al : Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000; 13 : 1210–1217. Article CAS Google Scholar Ramos F, Kotliar C, Alvarez D, et al : Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63 : 276–282. Article Google Scholar Download references
No takes yet. Share an insight, caveat, or question.
Kiyomoto et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Hypertension managementMore from Hypertension Research